rs2376805

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000815.5(GABRD):​c.69-19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.82 in 1,568,616 control chromosomes in the GnomAD database, including 528,265 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.81 ( 50323 hom., cov: 36)
Exomes 𝑓: 0.82 ( 477942 hom. )

Consequence

GABRD
NM_000815.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.221

Publications

17 publications found
Variant links:
Genes affected
GABRD (HGNC:4084): (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
GABRD Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics, ClinGen
  • epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • epilepsy, idiopathic generalized, susceptibility to, 10
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-2024923-G-A is Benign according to our data. Variant chr1-2024923-G-A is described in ClinVar as Benign. ClinVar VariationId is 256824.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GABRDNM_000815.5 linkc.69-19G>A intron_variant Intron 1 of 8 ENST00000378585.7 NP_000806.2
GABRDXM_017000936.2 linkc.755G>A p.Arg252Gln missense_variant Exon 1 of 8 XP_016856425.1
GABRDXM_011541194.4 linkc.108-19G>A intron_variant Intron 1 of 8 XP_011539496.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GABRDENST00000378585.7 linkc.69-19G>A intron_variant Intron 1 of 8 1 NM_000815.5 ENSP00000367848.4

Frequencies

GnomAD3 genomes
AF:
0.813
AC:
123660
AN:
152152
Hom.:
50293
Cov.:
36
show subpopulations
Gnomad AFR
AF:
0.795
Gnomad AMI
AF:
0.934
Gnomad AMR
AF:
0.768
Gnomad ASJ
AF:
0.904
Gnomad EAS
AF:
0.719
Gnomad SAS
AF:
0.781
Gnomad FIN
AF:
0.847
Gnomad MID
AF:
0.892
Gnomad NFE
AF:
0.830
Gnomad OTH
AF:
0.827
GnomAD2 exomes
AF:
0.803
AC:
200186
AN:
249240
AF XY:
0.807
show subpopulations
Gnomad AFR exome
AF:
0.794
Gnomad AMR exome
AF:
0.739
Gnomad ASJ exome
AF:
0.883
Gnomad EAS exome
AF:
0.717
Gnomad FIN exome
AF:
0.841
Gnomad NFE exome
AF:
0.831
Gnomad OTH exome
AF:
0.824
GnomAD4 exome
AF:
0.821
AC:
1162309
AN:
1416348
Hom.:
477942
Cov.:
23
AF XY:
0.820
AC XY:
579931
AN XY:
707314
show subpopulations
African (AFR)
AF:
0.800
AC:
26058
AN:
32554
American (AMR)
AF:
0.744
AC:
33141
AN:
44556
Ashkenazi Jewish (ASJ)
AF:
0.887
AC:
22841
AN:
25764
East Asian (EAS)
AF:
0.727
AC:
28690
AN:
39438
South Asian (SAS)
AF:
0.770
AC:
65594
AN:
85166
European-Finnish (FIN)
AF:
0.843
AC:
44090
AN:
52304
Middle Eastern (MID)
AF:
0.843
AC:
4792
AN:
5684
European-Non Finnish (NFE)
AF:
0.829
AC:
888664
AN:
1072020
Other (OTH)
AF:
0.823
AC:
48439
AN:
58862
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
10380
20760
31140
41520
51900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19956
39912
59868
79824
99780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.813
AC:
123740
AN:
152268
Hom.:
50323
Cov.:
36
AF XY:
0.811
AC XY:
60364
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.795
AC:
33027
AN:
41542
American (AMR)
AF:
0.767
AC:
11740
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.904
AC:
3139
AN:
3472
East Asian (EAS)
AF:
0.720
AC:
3730
AN:
5182
South Asian (SAS)
AF:
0.780
AC:
3771
AN:
4834
European-Finnish (FIN)
AF:
0.847
AC:
9002
AN:
10622
Middle Eastern (MID)
AF:
0.884
AC:
258
AN:
292
European-Non Finnish (NFE)
AF:
0.830
AC:
56472
AN:
68002
Other (OTH)
AF:
0.828
AC:
1751
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1286
2573
3859
5146
6432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
882
1764
2646
3528
4410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.829
Hom.:
9602
Bravo
AF:
0.808
Asia WGS
AF:
0.755
AC:
2631
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Epilepsy, idiopathic generalized, susceptibility to, 10 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Idiopathic generalized epilepsy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.1
DANN
Benign
0.25
PhyloP100
-0.22
PromoterAI
0.00060
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2376805; hg19: chr1-1956362; COSMIC: COSV66080160; COSMIC: COSV66080160; API